<DOC>
	<DOCNO>NCT02580149</DOCNO>
	<brief_summary>To investigate treatment ticagrelor mitigate transient loss endothelium-dependent vasodilatation resistance vasculature follow short period ischemia , compare clopidogrel standard clinical dos . The effect ticagrelor clopidogrel study load dose two week period regular intake FBF response vasodilator acetylcholine nitroglycerin 10 min 20 min forearm ischemia , respectively .</brief_summary>
	<brief_title>The Effect Ticagrelor Clopidogrel Endothelial Function During Acute Chronic Treatment</brief_title>
	<detailed_description>Ischemia-reperfusion ( IR ) cause tissue injury . Preclinical animal data suggest ticagrelor clopidogrel protect IR injury due inhibition cellular adenosine uptake NO-synthase stimulation . It unclear action part beneficial clinical effect ticagrelor patient history acute coronary syndrome . The preventive action ticagrelor IR injury may also interest peripheral vasculature , IR injury know result endothelial dysfunction . This study aim investigate treatment ticagrelor mitigate transient loss endothelium-dependent vasodilatation resistance vasculature follow short period ischemia , compare clopidogrel standard clinical dos . We study effect ticagrelor clopidogrel load dose two week period regular intake forearm blood flow ( FBF ) reactivity response vasodilator acetylcholine ( ACh ; endothelium-dependent agonist ) nitroglycerin ( GTN ; endothelium-independent vasodilator ) 10 min 20 min forearm ischemia , respectively</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Healthy male subject ; 18 40 year age Body mass index 18 27 kg/m2 Written inform consent Normal find medical &amp; bleed history Nonsmoking Regular intake medication include OTC drug herbal within 2 week IMP administration Known coagulation disorder ( e.g . haemophilia , von WillebrandÂ´s disease ) Known disorder increase bleed risk ( e.g . peridontosis , haemorrhoid , acute gastritis , peptic ulcer , intestinal ulcer ) Known sensitivity common cause bleeding ( e.g . nasal ) History thromboembolism History occlusive vascular disease History vascular anomaly Impaired liver function ( AST , ALT , gGT , bilirubin &gt; 2 x ULN ) Impaired renal function ( serum creatinine &gt; 1.3 mg/dl ) Any relevant deviation normal range clinical chemistry , haematology urine analysis HIV1/2Ab , HbsAg HCVAb positive serology Systolic blood pressure 145 mmHg , diastolic blood pressure 95 mmHg Known allergy test agent study Regular daily consumption litre xanthinecontaining beverage 40g alcohol Participation another clinical trial precede 3 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>